These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer. Gagliano-Jucá T; Travison TG; Nguyen PL; Kantoff PW; Taplin ME; Kibel AS; Manley R; Hally K; Bearup R; Beleva YM; Huang G; Edwards RR; Basaria S J Pain Symptom Manage; 2018 Feb; 55(2):307-317.e1. PubMed ID: 28941963 [TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer. Wadosky KM; Koochekpour S Oncotarget; 2016 Sep; 7(39):64447-64470. PubMed ID: 27487144 [TBL] [Abstract][Full Text] [Related]
12. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study. Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429 [TBL] [Abstract][Full Text] [Related]
13. Intermittent androgen-deprivation therapy in prostate cancer: a critical review focused on phase 3 trials. Sciarra A; Abrahamsson PA; Brausi M; Galsky M; Mottet N; Sartor O; Tammela TL; Calais da Silva F Eur Urol; 2013 Nov; 64(5):722-30. PubMed ID: 23628492 [TBL] [Abstract][Full Text] [Related]
14. The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review. Edmunds K; Tuffaha H; Scuffham P; Galvão DA; Newton RU Support Care Cancer; 2020 Dec; 28(12):5661-5671. PubMed ID: 32699997 [TBL] [Abstract][Full Text] [Related]
15. Androgen deprivation therapy: evidence-based management of side effects. Ahmadi H; Daneshmand S BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025 [TBL] [Abstract][Full Text] [Related]
16. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Rydzewska LHM; Burdett S; Vale CL; Clarke NW; Fizazi K; Kheoh T; Mason MD; Miladinovic B; James ND; Parmar MKB; Spears MR; Sweeney CJ; Sydes MR; Tran N; Tierney JF; Eur J Cancer; 2017 Oct; 84():88-101. PubMed ID: 28800492 [TBL] [Abstract][Full Text] [Related]
17. Associations between Peripheral Thromboembolic Vascular Disease and Androgen Deprivation Therapy in Asian Prostate Cancer Patients. Lu YC; Huang CY; Yeh HM; Hong JH; Chang CH; Muo CH; Chung SD; Yang TK; Jaw FS; Chung CJ Sci Rep; 2019 Oct; 9(1):14231. PubMed ID: 31578427 [TBL] [Abstract][Full Text] [Related]
19. Effects of androgen deprivation on cerebral morphometry in prostate cancer patients--an exploratory study. Chao HH; Hu S; Ide JS; Uchio E; Zhang S; Rose M; Concato J; Li CS PLoS One; 2013; 8(8):e72032. PubMed ID: 23977199 [TBL] [Abstract][Full Text] [Related]
20. A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy. Lee CE; Leslie WD; Lau YK BMC Cancer; 2012 Mar; 12():103. PubMed ID: 22436542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]